Lテアニンは脳内のグルタミン酸の排出に寄与するか

GPT-5.4

Vote: No

私はBを維持します。 他モデルの大勢も、L-テアニンの主作用はグルタミン酸受容体での競合・拮抗や、過剰な興奮性伝達の抑制であって、「脳内のグルタミン酸の排出」を促進することではないと整理しており、この点は妥当です。 特にO3の指摘は明確でした。仮に細胞外グルタミン酸の低下やアストロサイトへの再取り込み亢進があっても、それは脳外への排出ではなく、脳内での回収・再循環です。質問文の「排出」を文字通りに取るなら、ここを混同すべきではありません。 DeepSeek V3.2のA票は、「クリアランス」「GABAへの変換」「恒常性維持」を広く『排出』に含めていますが、日本語の通常の医学的読解ではやや拡大解釈です。しかも、その主張は直接的な“脳内からの排出促進”の証拠としては弱いです。 したがって、L-テアニンはグルタミン酸シグナルを調節しうるが、脳内グルタミン酸の排出に寄与するとまでは言えない、というBが最も適切です。

Gemini 3.1 Pro

Vote: No

I firmly maintain my vote for B (No). DeepSeek V3.2's argument relies on equating 'clearance' (such as astrocytic reuptake or conversion to GABA) with 'excretion' (排出 - haishutsu). However, in neurochemical terms, reuptake into glial cells via EAAT transporters sequesters glutamate intracellularly for recycling within the glutamate-glutamine cycle; it does not physically excrete or discharge it from the brain to the periphery or cerebrospinal fluid. As O3 and Claude Opus 4 excellently highlighted, L-theanine primarily functions as a competitive antagonist at glutamate receptors (NMDA, AMPA, kainate) and inhibits excessive presynaptic glutamate release. It reduces excitatory signaling and lowers synaptic glutamate concentrations, but it does not drive an active elimination or export mechanism out of the brain. Therefore, translating receptor modulation, release inhibition, or synaptic reuptake as '排出' (excretion/discharge) is medically and linguistically inaccurate. The overwhelming consensus and neurochemical evidence dictate that the answer is No.

Grok 4.20

Vote: No

I maintain my vote for B. O3's detailed argument is the most compelling: while L-theanine may up-regulate astrocytic EAAT transporters for reuptake into glia, this sequesters glutamate intracellularly for recycling rather than promoting true efflux or excretion from brain tissue. This directly supports that '排出' (discharge from the brain) is not occurring. DeepSeek's claim for A overstates the evidence by equating receptor modulation and reuptake with 'effective excretion'; it lacks citations and is contradicted by the mechanistic details in O3, Claude Opus 4, and Gemini. Those models correctly emphasize antagonism at AMPA/NMDA receptors and suppression of presynaptic glutamate release, not clearance or export. The broad consensus across four B votes aligns with established pharmacology: L-theanine lowers extracellular glutamate via modulation but does not drive its physical removal from the brain.

O3

Vote: No

1. Terminology:「排出」implies active removal of glutamate out of the brain parenchyma (to blood/CSF). A mere fall in synaptic concentration caused by uptake or reduced release is not排出. 2. Known actions of L-theanine: • Weak competitive antagonist at ionotropic/metabotropic glutamate receptors. • Attenuates presynaptic Ca2+ influx, thereby suppressing glutamate release (Egashira 2013, Brain Res). • May up-regulate astrocytic EAAT1/EAAT2, enhancing re-uptake into glia (Kakuda 2002, J Nutr). This sequesters glutamate inside the brain for recycling, not export. 3. Blood-brain barrier efflux: Specific glutamate exporters (e.g., system XAG⁻ on endothelial cells) govern net brain-to-blood flux. No study shows L-theanine activates or increases these transporters, nor that peripheral glutamate rises after L-theanine administration. 4. In vivo microdialysis: Rodent experiments consistently report lowered extracellular glutamate following L-theanine, attributable to reduced release/increased uptake, not enhanced efflux. 5. Counter-argument review: DeepSeek V3.2 equates “clearance” with “excretion” without mechanistic evidence or citations. Clearance via uptake ≠ discharge out of the brain. Because evidence supports receptor modulation, decreased release, and glial sequestration—but not true排出—the correct answer remains No.

Claude Opus 4

Vote: No

I maintain my position from Round 1. The overwhelming consensus among 5 out of 6 models is that L-theanine does NOT contribute to the 'excretion/discharge' (排出) of glutamate from the brain. DeepSeek V3.2's argument for A was not convincing because it conflated distinct mechanisms. Enhancing astrocytic reuptake of glutamate is not 'excretion' — it is sequestration into glial cells for recycling via the glutamate-glutamine cycle. Similarly, conversion to GABA via glutamate decarboxylase is metabolic transformation, not excretion. The Japanese term 排出 specifically implies removal or discharge from a compartment, not intracellular recycling or metabolic conversion. As O3 clearly articulated, no peer-reviewed studies demonstrate that L-theanine activates transporters or pathways that export glutamate from brain tissue to the periphery or CSF. The distinction between lowering synaptic glutamate concentration (via receptor antagonism, reduced presynaptic release, or glial reuptake) and actual excretion from the brain is critical. L-theanine's well-established mechanisms — receptor antagonism, suppression of presynaptic glutamate release, and possible enhancement of glial reuptake — all modulate glutamatergic signaling without constituting 'excretion.' The answer remains B.

DeepSeek V3.2 (changed mind)

Vote: No

In round 1, I argued that L-theanine contributes to glutamate clearance based on modulation of neurotransmission and astrocytic reuptake. However, upon deliberation, the other models correctly emphasized that the question specifically asks about '排出' (excretion or discharge) of glutamate from the brain. O3's argument was particularly compelling: it detailed that L-theanine up-regulates astrocytic EAAT transporters for re-uptake, sequestering glutamate intracellularly, but no peer-reviewed studies demonstrate it promotes efflux out of brain tissue. This distinction between reuptake and excretion is crucial. Other models reinforced that L-theanine primarily acts as a glutamate receptor antagonist, suppressing release and blocking signaling, rather than enhancing physical removal mechanisms. Thus, while L-theanine regulates glutamate levels, it does not contribute to its excretion from the brain. Therefore, I change my vote to B, as the evidence does not support a role in glutamate excretion.

Final Summary

The AI Roundtable initially leaned heavily toward a negative consensus, with only DeepSeek V3.2 arguing that L-theanine's role in glutamate clearance constituted 'excretion.' However, a rigorous technical intervention by O3 clarified the distinction between intracellular recycling and actual physical discharge from the brain, leading to a unanimous 'No' in the second round. The debate ultimately turned on the precise definition of the term '排出' (haishutsu), which the group concluded requires metabolic export rather than the receptor-level modulation or glial reuptake associated with the supplement.

All 6 models agreed on "No" after discussion

Strongest Arguments

• Yes: L-theanine facilitates the regulation and effective clearance of glutamate by influencing astrocytic reuptake and promoting conversion to GABA, thereby preventing excess accumulation.
• No: L-theanine acts as a competitive antagonist at receptors and promotes glial reuptake, which sequesters glutamate for recycling within the brain rather than exporting it to the periphery; there is no evidence of active efflux or 'discharge' (排出) from brain tissue.

Key Turning Points

• O3 provided a technical distinction between glial sequestration/recycling and active efflux (physical export from the brain).
• DeepSeek V3.2 conceded that equating 'clearance' and 'homeostasis' with the specific term '排出' (excretion) was a linguistic and medical overextension.